About: Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China
Creator	Zhang, Xie Ye, Hua Dai, Yuanrong Huang, Xiaoying Leng, Zhefeng Li, Jifa Sun, Yangjie Xiao, Zhongxiang Yang, Lehe Ye, Xinxin Yu, Wenwen Zhao, Chengguang Zheng, Legui Zheng, Long
Source	Elsevier; PMC
abstract	BACKGROUND: It has been reported that a fraction of recovered coronavirus disease 2019(COVID-19) patients have retested positive for SARS-CoV-2. Clinical characteristics and risk factors for retesting positive have not been studied extensively. METHODS: In this retrospective, single-center cohort study, we included adult patients (≥ 18 years old) diagnosed as COVID-19 in Affiliated Yueqing Hospital, Wenzhou Medical University, Zhejiang, China. All the patients were discharged before March 31, 2020, and were re-tested for SARS-CoV-2 RNA by real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) after meeting the discharge criteria. We retrospectively analyzed this cohort of 117 discharged patients and analyzed the differences between retest positive and negative patients in terms of demographics, clinical characteristics, laboratory findings, chest computed tomography (CT) features and treatment procedures. FINDINGS: Compared with the negative group, the positive group had a higher proportion of patients with comorbidities (Odds Ratio(OR) =2·12, 95% Confidence Interval(CI) 0·48–9·46; p = 0·029), longer hospital stay (OR=1·21, 95% CI 1·07–1·36; p = 0·008), a higher proportion of patients with lymphocytopenia (p = 0·036), a higher proportion of antibiotics treatment (p = 0·008) and glucocorticoids treatment (p = 0·003). Multivariable regression showed increasing odds of positive SARS-CoV-2 retest after discharge associated with longer hospital stay (OR=1·22, 95% CI 1·08–1·38; p = 0·001), and lymphocytopenia (OR=7·74, 95% CI 1·70–35·21; p = 0·008) on admission. INTERPRETATION: Patients with COVID-19 who met discharge criteria could still test positive for SARS-CoV-2 RNA. Longer hospital stay and lymphopenia could be potential risk factors for positive SARS-CoV-2 retest in COVID-19 patients after hospital discharge. FUNDING: Natural Science Foundation of Zhejiang Province, Medical Scientific Research Fund of Zhejiang Province, Wenzhou science and technology project
has issue date	2020-08-24(xsd:dateTime)
bibo:doi	10.1016/j.eclinm.2020.100492
has license	no-cc
sha1sum (hex)	76b471188bca772ed49bd79b5791857353ee5137
schema:url	https://doi.org/10.1016/j.eclinm.2020.100492
resource representing a document's title	Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China
has PubMed Central identifier	PMC7444491
schema:publication	EClinicalMedicine
resource representing a document's body	covid:76b471188bca772ed49bd79b5791857353ee5137#body_text
is schema:about of	named entity 'March' named entity 'Longer' named entity 'Confidence Interval' named entity 'patients' named entity 'demographics' named entity 'cohort' named entity 'antibiotics' named entity 'real-time' named entity '95% CI' named entity 'patients' named entity 'test' named entity '3D2' named entity 'CHEST COMPUTED TOMOGRAPHY' named entity 'RISK FACTORS' named entity 'features' named entity 'lymphocytopenia' named entity 'RNA' named entity 'lymphocytopenia' named entity 'hospital' named entity 'proportion' named entity 'Interpretation' named entity 'glucocorticoids' named entity 'higher' named entity 'retrospectively' named entity 'COVID-19' named entity 'laboratory' named entity '95% CI' named entity 'RNA' named entity 'positive and negative' named entity 'SARS-CoV-2' named entity 'glucocorticoids' named entity 'COVID' named entity 'CD8 +' named entity 'logistic regression' named entity 'lymphocytopenia' named entity 'SARS-CoV-2' named entity 'virus' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'IBM' named entity 'diabetes' named entity 'pneumonia' named entity 'skewed distribution' named entity 'lymphocytopenia' named entity 'Wenzhou Medical University' named entity 'SARS-CoV-2' named entity 'homeostasis' named entity 'respiratory tract' named entity 'MERS' named entity 'neutrophil' named entity 'relative risk' named entity 'Wuhan' named entity 'hospital stays' named entity 'MCP1' named entity 'antibiotics' named entity 'tested positive' named entity 'C-reactive protein' named entity 'glucocorticoids' named entity 'COVID' named entity 'infection' named entity 'Lymphocytes' named entity 'diagnostic criteria' named entity 'virus' named entity 'Biotechnology' named entity 'glucocorticoid' named entity 'IL-1b' named entity 'viral pneumonia' named entity 'data acquisition' named entity 'RT-PCR' named entity 'feces'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software